Antioxidant Mechanisms of Ferulic Acid in Skincare, Vitamin C/E Synergy, and Stable Delivery Applications
Antioxidant Mechanisms of Ferulic Acid in Skincare, Vitamin C/E Synergy, and Stable Delivery Applications
1. Ingredient Properties of Ferulic Acid
1.1 Basic Information
Ferulic acid, abbreviated as FA, is chemically known as 4-hydroxy-3-methoxycinnamic acid and belongs to the class of hydroxycinnamic phenolic acids. Its core value in skincare comes from the antioxidant capacity conferred by its phenolic acid structure. Ferulic acid is mainly used to reduce oxidative stress caused by ultraviolet radiation, air pollution, and inflammatory conditions, and it is often combined with vitamin C and vitamin E to build an antioxidant system.
1.2 Plant Sources and Existing Forms
Ferulic acid is widely present in plants, especially in cereal brans and the cell walls of grasses. It often exists in bound forms and can be linked to cell wall components such as arabinoxylan and lignin through ester or ether bonds. In plants, it participates in cell wall cross-linking, thereby enhancing the structural strength and environmental tolerance of plant cell walls.
Ferulic acid, or its bound forms, can be found in plant-derived raw materials such as wheat bran, corn bran, rice bran, oats, rye, and barley. Plants use ferulic acid as part of their cell wall defense system, while skincare formulations utilize the free radical-scavenging and stabilizing effects derived from the molecular structure of ferulic acid.
2. Chemical Structure and Antioxidant Basis of Ferulic Acid
2.1 Molecular Formula and Structural Formula
Molecular formula: C₁₀H₁₀O₄
Condensed structural formula:
HO—C6H3(OCH3)—CH=CH—COOH
Structural schematic:

Structural moiety | Chemical characteristics | Contribution to antioxidant activity |
Phenolic hydroxyl group (–OH) | A hydrogen-donating group on the benzene ring | Provides hydrogen atoms or electrons to free radicals and serves as the key site for direct free radical scavenging |
Methoxy group (–OCH₃) | An electron-donating substituent | Increases the electron density of the aromatic ring and helps stabilize the phenoxy radical formed after reaction |
Conjugated side chain (–CH=CH–COOH) | An α,β-unsaturated carboxylic acid side chain connected to the benzene ring | Expands electron delocalization and reduces the reactivity of radical intermediates |
2.2 Structure Determines Antioxidant Capacity
The antioxidant capacity of ferulic acid results from the coordinated action of three structural units. The phenolic hydroxyl group is the initiating site for free radical-scavenging reactions. Free radicals are highly reactive and can easily abstract electrons or hydrogen atoms from sebum, cell membrane lipids, or proteins. The phenolic hydroxyl group of ferulic acid can preferentially participate in these reactions by donating a hydrogen atom or electron to free radicals, thereby lowering their reactivity.
The methoxy group enhances the electron-donating ability of the aromatic ring, making it easier for the phenolic hydroxyl group to participate in hydrogen donation. After ferulic acid loses a hydrogen atom, it forms a phenoxy radical. The methoxy group helps stabilize this radical through electronic effects, reducing the likelihood that it will continue attacking nearby molecules. The conjugated side chain allows the benzene ring and the unsaturated carboxylic acid structure to form a continuous conjugated system. After ferulic acid forms a phenoxy radical, the unpaired electron can be delocalized between the aromatic ring and the side chain, lowering the energy and reactivity of the radical intermediate.
The core antioxidant mechanism and synergistic effects of ferulic acid are shown in the figure below. Ferulic acid neutralizes free radicals by donating hydrogen atoms or electrons through its phenolic hydroxyl group. The phenoxy radical formed after the reaction can be stabilized through delocalization across the aromatic ring and conjugated side chain. At the same time, ferulic acid may participate in Nrf2-related cellular antioxidant defense and forms a classic synergistic antioxidant system with vitamin C and vitamin E.

3. Reaction Mechanism by Which Ferulic Acid Neutralizes Free Radicals
3.1 Development of Oxidative Damage in Skin
Ultraviolet radiation, air pollution, inflammatory responses, and high-temperature environments can promote the generation of ROS, or reactive oxygen species, in the skin. ROS include superoxide anions, hydroxyl radicals, peroxyl radicals, and other reactive species. They can attack sebum, cell membrane lipids, proteins, and DNA, leading to lipid peroxidation, impaired barrier function, enhanced inflammatory signaling, collagen degradation, and abnormal pigmentation.
The danger of oxidative damage lies in its chain propagation. After one free radical attacks a lipid molecule, a new lipid radical may be generated. This newly formed radical can continue attacking surrounding molecules, thereby expanding oxidative damage. An effective antioxidant needs to reduce free radical reactivity before the chain reaction spreads further.
3.2 Free Radical-Scavenging Reaction of Ferulic Acid
Ferulic acid can participate in hydrogen atom transfer or electron transfer through its phenolic hydroxyl group. Taking a peroxyl radical as an example, the reaction can be simplified as:
FA—OH + ROO• → FA—O• + ROOH
Where:
Symbol | Meaning |
FA—OH | Ferulic acid |
ROO• | Peroxyl radical |
FA—O• | Ferulic acid phenoxy radical |
ROOH | Hydroperoxide |
In this reaction, ferulic acid converts the highly reactive peroxyl radical into a less reactive hydroperoxide, while ferulic acid itself forms a relatively stable phenoxy radical.
3.3 Stability of Ferulic Acid After Reaction
The FA–O• formed after hydrogen donation by ferulic acid is a phenoxy radical. Its unpaired electron is not confined to the oxygen atom; instead, it can undergo resonance delocalization through the phenoxy group and the π system of the aromatic ring. At the same time, the para-linked –CH=CH–COOH conjugated side chain of ferulic acid further expands the range of electron delocalization, lowering the energy and reactivity of the radical intermediate. The methoxy group also stabilizes radical resonance structures on the aromatic ring through its electron-donating resonance effect, thereby enhancing the stability of ferulic acid after hydrogen donation.
4. Ferulic Acid and the Skin’s Endogenous Antioxidant Defense
4.1 Direct Antioxidant Activity and Cellular Defense
The effect of ferulic acid on oxidative stress in the skin involves two levels.
The first level is direct antioxidant activity. Ferulic acid reduces lipid peroxidation and free radical chain reactions by donating hydrogen through its phenolic hydroxyl group and stabilizing the resulting phenoxy radical through resonance.
The second level is cellular defense regulation. Studies using cellular, animal, and wound inflammation-related models have shown that ferulic acid may influence the Nrf2 pathway, also known as the nuclear factor erythroid 2-related factor 2 pathway. Nrf2 is an important transcription factor involved in the cellular response to oxidative stress and can regulate the expression of various antioxidant and detoxification-related genes.
4.2 How the Nrf2 Pathway Enhances Cellular Antioxidant Capacity
Under normal conditions, Nrf2 is regulated by Keap1, or Kelch-like ECH-associated protein 1, and is targeted for degradation. When cells are exposed to oxidative stress, Nrf2 is more likely to enter the nucleus and bind to AREs, or antioxidant response elements, thereby promoting the expression of defense-related genes.
Common downstream factors of the Nrf2 pathway include:
Downstream factor | Full name | Main function |
HO-1 | Heme Oxygenase-1 | Antioxidant, anti-inflammatory, and cytoprotective effects |
NQO1 | NAD(P)H Quinone Dehydrogenase 1 | Participates in quinone detoxification and redox homeostasis |
GCLC | Glutamate-Cysteine Ligase Catalytic Subunit | Participates in glutathione synthesis |
Skin-related studies have shown that ferulic acid is associated with Nrf2 activation in wound-induced inflammation models and may influence keratinocyte migration and inflammatory responses. In skincare applications, this suggests that ferulic acid may not only directly scavenge free radicals on the skin surface, but may also participate in the regulation of cellular antioxidant defense under certain concentration and delivery conditions. However, in ordinary topical skincare applications, the actual performance of Nrf2 pathway-related effects is affected by formulation concentration, stability, skin delivery efficiency, site of action, and skin condition.
5. Synergistic Antioxidant Network of Ferulic Acid with Vitamin C and Vitamin E
5.1 Division of Roles Among the Three Antioxidants
The combination of ferulic acid with vitamin C and vitamin E is one of the better-studied antioxidant systems in skincare formulations.
Ingredient | English name and abbreviation | Solubility characteristics | Main function |
Vitamin C | L-Ascorbic Acid, LAA | Water-soluble | Scavenges free radicals in the aqueous phase and participates in vitamin E regeneration |
Vitamin E | α-Tocopherol | Lipid-soluble | Protects cell membranes and sebum and interrupts lipid peroxidation |
Ferulic acid | Ferulic Acid, FA | Phenolic acid | Scavenges free radicals and improves the stability of the vitamin C/vitamin E system |
Vitamin E mainly protects lipid structures, especially unsaturated lipids in cell membranes and sebum. Vitamin C mainly acts in aqueous environments and can help restore oxidized vitamin E to its antioxidant-active form. Ferulic acid supplements free radical-scavenging capacity and improves the formulation stability of vitamin C and vitamin E.
5.2 Formation of an Antioxidant Regeneration Network
Ultraviolet radiation / pollution → increased ROS and induced lipid peroxidation → vitamin E intercepts lipid radicals → vitamin E becomes oxidized → vitamin C helps regenerate oxidized vitamin E → ferulic acid scavenges free radicals and stabilizes the C/E system → overall antioxidant and photoprotective performance is enhanced
A classic study showed that adding 0.5% ferulic acid to a topical system containing 15% L-ascorbic acid and 1% α-tocopherol improved the chemical stability of vitamin C and vitamin E. Under simulated solar radiation, this combination increased the skin’s photoprotective performance from approximately four-fold to approximately eight-fold, using erythema and sunburn cell formation as evaluation indicators. This result reflects the auxiliary protective effect of the antioxidant system against UV-induced oxidative damage. It is not equivalent to an SPF value and cannot replace sunscreen products.
6. pH, Solubility, and Stability of Ferulic Acid in Formulations
6.1 Effect of pH on the State of Ferulic Acid
Ferulic acid is a weakly acidic molecule, and its carboxylic acid group ionizes in response to changes in pH. Under low-pH conditions, ferulic acid exists more predominantly in its non-ionized form. As pH increases, the degree of ionization increases, and water solubility improves. The carboxyl group of ferulic acid has a pKa of approximately 4.61. When the formulation pH approaches or exceeds this value, the proportion of carboxylate salt increases, and water solubility improves.
pH condition | State of ferulic acid | Formulation significance |
Around pH 3 | Higher proportion of non-ionized form | Better stability; suitable for pairing with low-pH L-ascorbic acid systems, but water solubility is limited |
pH close to or higher than the carboxyl pKa, approximately 4.61 | Increased ionization | Improved water solubility; however, in systems containing water, light, oxygen, heat, or metal ions, the risk of degradation and discoloration may increase |
Alkaline pH | Significant ionization | Higher solubility, but unfavorable for ferulic acid stability and unsuitable for classic L-ascorbic acid systems |
A pH of around 3 offers certain advantages for ferulic acid and L-ascorbic acid systems. An acidic environment helps ferulic acid remain in a higher proportion of its non-ionized form and also matches the skin absorption conditions required by L-ascorbic acid. Studies have shown that L-ascorbic acid enters the skin more effectively when the pH is below 3.5.
However, low pH also brings solubility limitations. Ferulic acid has limited water solubility under low-pH conditions, so formulations need suitable solvents, co-solvent systems, or carrier systems to maintain dispersion and stability. If pH is simply raised to improve solubility, ferulic acid ionization and exposure in the aqueous phase will increase. In the presence of factors such as light, oxygen, heat, or metal ions, the risks of oxidation, isomerization, discoloration, or degradation may also increase.
6.2 Formulation Factors Affecting the Stability of Ferulic Acid
Topical ferulic acid formulations need to address solubility, stability, compatibility, and tolerability at the same time.
Formulation factor | Effect on ferulic acid | Design focus |
pH | Affects ionization, solubility, and degradation risk | Usually requires balancing acidic stability with skin tolerability |
Solvent system | Determines whether ferulic acid can be sufficiently dissolved or stably dispersed at low pH | Polyols, alcohols, or other co-solvent systems may be used |
Light and oxygen | Accelerate oxidation and color darkening | Light protection, oxygen exclusion, and stable packaging are needed |
Metal ions | May promote oxidation reactions | Chelating agents and antioxidant protective systems may be incorporated |
Type of vitamin C | Determines pH requirements and compatibility logic | LAA and vitamin C derivatives should not be evaluated using the same criteria |
Skin condition | Affects stinging, irritation, and tolerability | Sensitive skin and barrier-impaired skin should use controlled application frequency |
7. Role of Nanocarriers in Ferulic Acid Delivery
7.1 Challenges in Topical Delivery of Ferulic Acid
When ferulic acid is used in topical skincare, its main limitations include low water solubility, environmental instability, and the stratum corneum barrier.
Challenge | Cause | Impact on product performance |
Limited water solubility | Higher proportion of non-ionized form at low pH | May affect formulation dispersion and effective concentration |
Susceptibility to environmental factors | Light, oxygen, heat, metal ions, and pH changes can all promote degradation | Reduced activity and color darkening |
Stratum corneum barrier | The lipid structure of the stratum corneum limits the entry of exogenous ingredients | Skin bioavailability is restricted |
7.2 How Nanocarriers Improve the Utilization of Ferulic Acid
Common delivery systems include nanocapsules, liposomes, transfersomes, nanostructured lipid carriers, and nanoemulsions. Their effects on ferulic acid are mainly reflected in four aspects:
Function | Significance for ferulic acid |
Improved dispersion | Reduces the risk of crystallization and allows ferulic acid to be distributed more uniformly in the formulation |
Enhanced stability | Reduces direct exposure of ferulic acid to the aqueous phase, oxygen, and light |
Controlled release | Delays rapid loss of the active ingredient and improves sustained action time |
Enhanced distribution in the stratum corneum | Influences retention and release in the stratum corneum through lipid interactions, hydration effects, particle size, and surface properties |
Studies on topical ferulic acid nanogel have shown that nanoencapsulation combined with an acidic environment below the pKa of ferulic acid helps improve the appearance and chemical stability of topical ferulic acid gels. Research on transdermal nanodelivery also indicates that well-designed nanocarriers may improve the retention, release, or delivery performance of active ingredients in the stratum corneum and related epidermal regions through factors such as stratum corneum hydration, effects on lipid structure, particle size control, system deformability, and surface charge.
The action sites of nanocarriers are usually concentrated in the stratum corneum, follicular openings, and superficial epidermal layers. For antioxidant skincare, these locations are practically meaningful because oxidative stress induced by ultraviolet radiation and pollution first occurs at the skin surface and in the epidermal region. Ferulic acid does not need to penetrate deeply into the dermis in large amounts to exert its basic antioxidant value. The key is to maintain its stability and allow sustained release in the stratum corneum and related epidermal areas.
8. Evaluating the Effectiveness of Ferulic Acid Skincare Products
8.1 Whether a Rational Antioxidant System Has Been Formed
The presence of ferulic acid does not necessarily mean that a product has strong antioxidant effects. What matters is whether ferulic acid forms a logical combination with vitamin C, vitamin E, or other antioxidants. Vitamin C is responsible for antioxidant activity in the aqueous phase and can participate in vitamin E regeneration. Vitamin E is responsible for lipid-phase protection. Ferulic acid supplements free radical-scavenging capacity and improves the stability of the C/E system. The combination of these three antioxidants is currently one of the classic antioxidant systems with relatively strong research support and clear functional division.
8.2 Whether the Type of Vitamin C Is Appropriate
If a formulation uses LAA, or L-ascorbic acid, it usually requires an acidic pH to support skin absorption. If the formulation uses vitamin C derivatives, such as ascorbyl glucoside, magnesium ascorbyl phosphate, or tetrahexyldecyl ascorbate, their stability, conversion pathways, pH requirements, and evidence systems are all different. Research findings based on LAA should not be directly applied to these derivatives.
8.3 Whether Stability Is Adequately Protected
Ferulic acid and L-ascorbic acid systems are sensitive to light, oxygen, temperature, and metal ions. Dark, light-protective packaging; sealed pump containers; reduced air exposure; control of metal ions; and optimized solvent systems can all affect the retention of active ingredients in the product. If a product containing vitamin C and ferulic acid has clearly turned dark yellow, orange-brown, or brown, this usually indicates an increased degree of oxidation. A slight color change does not necessarily mean complete loss of efficacy, but obvious darkening often suggests that a substantial portion of the antioxidant system has been consumed.
8.4 Whether pH and Tolerability Are Balanced
An acidic environment is beneficial for LAA systems and ferulic acid stability, but it may also increase stinging, redness, or dryness. Sensitive skin, barrier-impaired skin, and skin in an inflammatory state should use such products less frequently and pair them with moisturizing and barrier-repair products. Ferulic acid itself is not an exfoliating acid, but it is often formulated with low-pH antioxidant systems, so skin tolerability still requires attention.
8.5 Whether the Delivery Technology Supports Stability and Release
The value of nanoencapsulation, lipid carriers, co-solvent systems, and polyol solvents lies in improving the dispersion, stability, and stratum corneum release of ferulic acid. An effective delivery design should keep ferulic acid stable in the formulation and allow it to continue exerting its effects on the skin surface.
9. Classification Tables of Representative Chemicals Related to the Antioxidant Mechanisms and Formulation Applications of Ferulic Acid in Skincare
Table 1. Core Ferulic Acid Ingredients, Derivatives, and Plant Cell Wall-Related Components
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Core ferulic acid ingredient | 1135-24-6 | Ferulic Acid | Moligand™, ≥99% | Used for studies on the antioxidant mechanism of ferulic acid, phenolic hydroxyl hydrogen-donation reactions, free radical scavenging, and the construction of vitamin C/vitamin E synergistic systems | |
Ferulic acid salt | 24276-84-4 | Sodium Ferulate | ≥99% | Water-soluble salt form of ferulic acid, used for comparing solubility, stability, and release behavior under different pH conditions | |
Ferulic acid ester derivative | 2309-07-1 | Methyl Ferulate | ≥99% | Used for studies on esterified ferulic acid structures, including changes in lipophilicity, structural modification, and structure–antioxidant activity relationships | |
Ferulic acid ester derivative | 4046-02-0 | Ethyl Ferulate | ≥97% | Ethyl ester derivative of ferulic acid, used for studies on lipid-phase antioxidant activity, skin delivery, and structure–activity comparison | |
Ferulic acid isomer | 537-73-5 | Isoferulic Acid | Moligand™, ≥98% | Isomeric reference compound of ferulic acid, used to study how positional changes of the phenolic hydroxyl and methoxy groups affect free radical-scavenging ability | |
Plant cell wall-related component | 458-35-5 | Coniferyl Alcohol | ≥98% | Component related to lignin biosynthesis, used for studies on plant cell wall cross-linking and the structural origins of hydroxycinnamic acids | |
Ferulic acid transformation-related compound | 121-33-5 | Vanillin | AR, ≥99% | Used for studies on ferulic acid oxidative transformation and aromatic metabolism, including degradation pathways and structural changes of plant phenolic acids | |
Ferulic acid transformation-related compound | 121-34-6 | Vanillic Acid | ≥98% | Ferulic acid-related phenolic acid metabolite, used for comparing aromatic ring substituents, phenolic acid structures, and antioxidant activity |
Table 2. Phenolic Acids, Polyphenols, and Structural Reference Compounds for Ferulic Acid
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Hydroxycinnamic acid structural reference | 501-98-4 | 4-Coumaric Acid | Moligand™, ≥98% | Demethoxylated structural reference compound of ferulic acid, used to study the effect of the methoxy group on phenoxy radical stabilization | |
Hydroxycinnamic acid structural reference | 331-39-5 | Caffeic Acid | Moligand™, ≥99% | Catechol-type hydroxycinnamic acid, used to compare the number of phenolic hydroxyl groups and free radical-scavenging capacity | |
Hydroxycinnamic acid structural reference | 530-59-6 | Sinapic Acid | ≥98% | Dimethoxy hydroxycinnamic acid, used to compare the number of methoxy substituents and phenoxy radical stability | |
Hydroxybenzoic acid structural reference | 149-91-7 | Gallic Acid | Moligand™, ≥99% | Representative polyhydroxy phenolic acid, used to compare reducing capacity, free radical-scavenging ability, and the number of phenolic hydroxyl groups | |
Hydroxybenzoic acid structural reference | 99-50-3 | 3,4-Dihydroxybenzoic Acid | ≥97% | Catechol-type hydroxybenzoic acid, used to study the relationship between phenolic hydroxyl arrangement and antioxidant activity | |
Hydroxybenzoic acid structural reference | 530-57-4 | Syringic Acid | ≥98% | Dimethoxy hydroxybenzoic acid, used to study aromatic ring methoxy substitution and radical stabilization effects | |
Plant polyphenolic acid | 327-97-9 | Chlorogenic Acid | Moligand™, ≥98% | Caffeic acid-derived plant polyphenolic acid, used for studies on plant-derived antioxidant activity and phenolic acid ester structures | |
Plant polyphenolic acid | 20283-92-5 | Rosmarinic Acid | ≥97% | Plant-derived polyphenolic acid, used for evaluating phenolic hydroxyl hydrogen-donation ability, free radical scavenging, and antioxidant models | |
Plant polyphenol | 501-36-0 | Resveratrol | Moligand™, ≥99% | Plant polyphenol antioxidant ingredient, used for studies on oxidative stress, inflammatory responses, and polyphenol structure–activity relationships | |
Plant polyphenol | 989-51-5 | (-)-Epigallocatechin Gallate | Moligand™, ≥98% | Representative tea polyphenol, used for free radical scavenging, protection against cellular oxidative damage, and polyphenol antioxidant evaluation | |
Phenolic antioxidant | 1948-33-0 | tert-Butylhydroquinone (TBHQ) | ≥98% | Phenolic antioxidant, used for free radical-scavenging assays, inhibition of lipid oxidation, and studies on cellular antioxidant defense |
Table 3. Vitamin C, Vitamin E, and Synergistic Antioxidant System Components
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Prototype vitamin C ingredient | 50-81-7 | L-Ascorbic Acid | Anhydrous grade, Moligand™, ACS, ≥99% | Classic component of the vitamin C/vitamin E/ferulic acid system, used for studies on aqueous-phase antioxidant activity, low-pH delivery, and photoprotective synergy | |
Water-soluble vitamin C derivative | 86404-04-8 | 3-O-Ethyl-L-Ascorbic Acid | Moligand™, ≥98% (HPLC) (T) | Stable vitamin C derivative, used for studies on antioxidant formulation stability, active release, and topical skincare systems | |
Water-soluble vitamin C derivative | 113170-55-1 | L-Ascorbic Acid 2-Phosphate Sesquimagnesium Salt Hydrate | Moligand™, ≥98% (HPLC) | Phosphate ester-type vitamin C derivative, used for aqueous-phase antioxidant studies, cellular models, and formulation stability evaluation | |
Water-soluble vitamin C derivative | 66170-10-3 | L-Ascorbic Acid-2-Phosphate Trisodium Salt | ≥96% | Phosphate salt-type vitamin C derivative, used for mild antioxidant systems, cellular antioxidant experiments, and stability comparisons | |
Lipid-soluble vitamin C derivative | 137-66-6 | L-Ascorbyl Palmitate | PharmPure™, USP | Lipid-soluble vitamin C derivative, used for oil-phase antioxidant studies, lipid peroxidation inhibition, and emulsion system research | |
Lipid-soluble vitamin C derivative | 183476-82-6 | Tetrahexyldecyl Ascorbate | Cosmetic grade, ≥90% | Lipid-soluble vitamin C derivative, used for oil-phase delivery, lipid-phase antioxidant activity, and skincare formulation development | |
Prototype vitamin E ingredient | 59-02-9 | D-α-Tocopherol | Moligand™, ≥97% (GC) | Active form of vitamin E, used for lipid-phase antioxidant studies, cell membrane protection, and ferulic acid/ascorbic acid synergy experiments | |
Prototype vitamin E ingredient | 10191-41-0 | DL-α-Tocopherol | ≥96% | Synthetic tocopherol, used for studies on lipid peroxidation inhibition, antioxidant formulation evaluation, and vitamin E reference research | |
Vitamin E derivative | 7695-91-2 | DL-α-Tocopherol Acetate | PharmPure™, European Pharmacopoeia (Ph. Eur.) | Stable vitamin E derivative/precursor, used for studies on vitamin E derivative stability, skin delivery, formulation stability, and hydrolytic conversion | |
Vitamin E-like antioxidant reference | 53188-07-1 | Trolox | ≥98%, white | Water-soluble vitamin E analog, used for antioxidant capacity evaluation, free radical-scavenging assays, and methodological reference studies | |
Endogenous antioxidant system component | 70-18-8 | Glutathione, Reduced Form | PharmPure™, European Pharmacopoeia (Ph. Eur.) | Endogenous cellular antioxidant molecule, used for studies on redox homeostasis, glutathione pathways, and cellular protection | |
Endogenous antioxidant system precursor | 616-91-1 | N-Acetyl-L-Cysteine (NAC) | PharmPure™, USP, Moligand™, European Pharmacopoeia (Ph. Eur.), ≥98.5% | Glutathione precursor, used for oxidative stress models, cellular antioxidant capacity studies, and reactive oxygen species reduction experiments | |
Lipid-phase antioxidant component | 303-98-0 | Coenzyme Q10 | ≥98% | Lipid-phase antioxidant component, used for studies on cell membrane oxidative protection, mitochondrial oxidative stress, and tocopherol synergy |
Table 4. Reagents for Oxidative Stress, Free Radical-Scavenging Evaluation, and Cellular Pathway Research
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Oxidative stress modeling reagent | 7722-84-1 | H755825 | Hydrogen Peroxide Solution | Suitable for microbiology, 3% | Cellular oxidative stress modeling reagent, used to evaluate the ability of ferulic acid to reduce reactive oxygen species levels and protect cells |
Stable free radical evaluation reagent | 1898-66-4 | 2,2-Diphenyl-1-picrylhydrazyl, containing 10–20% benzene | ≥97% (HPLC) | Stable free radical-scavenging assay reagent, used to evaluate the antioxidant capacity of ferulic acid, phenolic acids, and polyphenolic ingredients | |
Radical cation evaluation reagent | 30931-67-0 | 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) Diammonium Salt [AzBTS-(NH4)2] | ≥98% | Radical cation-scavenging assay reagent, used for antioxidant capacity measurement of phenolic acids, polyphenols, and vitamins | |
Peroxyl radical generator | 2997-92-4 | 2,2′-Azobis(2-methylpropionamidine) Dihydrochloride (AAPH) | ≥97% | Peroxyl radical-generating system reagent, used for lipid peroxidation models and evaluation of chain-breaking antioxidant capacity | |
Reactive oxygen species detection probe | 4091-99-0 | 2,7-Dichlorodihydrofluorescein Diacetate (DCFH-DA) | ≥97% | Intracellular reactive oxygen species fluorescent probe, used to evaluate the ability of ferulic acid to reduce cellular oxidative stress levels | |
Nrf2 pathway modulator | 4478-93-7 | Sulforaphane | Moligand™, ≥95% | Nrf2 pathway activation research reagent, used as a reference for studying the cellular antioxidant defense mechanism of ferulic acid | |
Nrf2 pathway modulator | 624-49-7 | Dimethyl Fumarate | Moligand™, ≥99% | Cellular antioxidant defense pathway research reagent, used for analysis of antioxidant and detoxification-related protein expression | |
Nrf2 pathway inhibitor | 846557-71-9 | ML385, Nrf2 Inhibitor | Moligand™, ≥99% | Nrf2 pathway inhibition research reagent, used to verify the cellular defense mechanism of ferulic acid |
Table 5. pH Adjustment, Co-Solubilization, Moisturizing, and Stabilizing Excipients
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Acidic pH adjuster | 77-92-9 | Anhydrous Citric Acid Powder | Anhydrous grade, UltraBio™, ≥99.5% (T) | Acidic system pH adjuster, used to construct low-pH vitamin C/ferulic acid formulation environments and for stability studies | |
Buffer salt | 68-04-2 | Trisodium Citrate | Anhydrous grade, USP | Component of citrate buffer systems, used for formulation pH control, acidic-environment stability, and skin tolerability studies | |
Metal ion chelator | 139-33-3 | Disodium EDTA | ≥99% | Metal ion chelator, used to reduce metal-catalyzed oxidation risk and protect the stability of vitamin C and ferulic acid systems | |
Metal ion chelator | 6381-92-6 | Ethylenediaminetetraacetic Acid Disodium Salt Dihydrate | UltraBio™, ultrapure grade, ≥98.5% | Hydrate-grade metal ion chelator, used for antioxidant formulation stability protection and control of oxidative discoloration | |
Low-water co-solvent | 64-17-5 | E111989 | Ethanol | Premium grade, water ≤0.3% | Co-solvent for phenolic acid ingredients, used for studies on ferulic acid solubility, low-water systems, and volatile-solvent formulations |
Moisturizing co-solvent | 56-81-5 | Glycerol | Anhydrous grade, UltraBio™, molecular biology grade, ≥99.5% (GC) | Polyol moisturizing ingredient, used for aqueous-phase system adjustment, low-pH antioxidant serums, and skin tolerability studies | |
Moisturizing co-solvent | 57-55-6 | 1,2-Propanediol | AR, ≥99% | Polyol co-solvent, used for dissolving, dispersing, and moisturizing systems containing ferulic acid and other phenolic acid actives | |
Moisturizing co-solvent | 504-63-2 | 1,3-Propanediol | ≥98% | Polyol co-solvent and moisturizer, used for antioxidant active dispersion, skin feel, and formulation stability studies | |
Moisturizing co-solvent | 107-88-0 | 1,3-Butanediol | Anhydrous grade, ≥99% | Polyol moisturizing co-solvent, used for dispersion, formulation stability, and skin feel studies in low-pH ferulic acid systems | |
Polymeric thickening and film-forming material | 25322-68-3 | Polyethylene Oxide | Viscosity 65–115 cps | Polymeric thickening and film-forming material, used for topical gels, active release models, and formulation rheology studies |
Table 6. Nanodelivery, Lipid Carrier, and Emulsifying/Dispersing Materials
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Nonionic emulsifier for oil-in-water systems | 9005-64-5 | Tween 20 (TWEEN® 20) | Viscous liquid | Nonionic emulsifying and dispersing material, used for aqueous dispersion systems, emulsification of phenolic acid actives, and stability studies | |
Nonionic emulsifier for oil-in-water systems | 9005-65-6 | Tween® 80 | Viscous liquid, preservative-free, low peroxide; low carbonyl | Low-peroxide nonionic emulsifier, used for nanoemulsions, lipid dispersion systems, and ferulic acid delivery stability studies | |
Oil-phase emulsifier | 1338-43-8 | Span 80 | Viscosity 1000–2000 mPa·s at 20 °C | Oil-phase emulsifying material, used for water-in-oil systems, nanoemulsion construction, and ferulic acid lipid carrier studies | |
Micelle and gel stabilizer | 9003-11-6 | K434429 | Kolliphor® P 407 | Oxyethylene content 71.5–74.9% | Block copolymer stabilizer, used for micelles, gel delivery systems, and stability evaluation of topical ferulic acid carriers |
Phospholipid carrier material | 8002-43-5 | Phospholipids from Sunflower, Non-GMO | Natural, with ≥60% phosphatidylcholine | Composite phospholipid carrier material, used for liposomes, nanocarriers, and ferulic acid stratum corneum delivery studies | |
Liposome membrane-stabilizing component | 57-88-5 | Cholesterol from Lanolin | PharmPure™, JP, BP, European Pharmacopoeia (Ph. Eur.), NF, ultrapure grade | Liposome membrane-stabilizing component, used for active ingredient loading, membrane fluidity regulation, and release behavior studies | |
Solid lipid matrix | 57-11-4 | Stearic Acid | Moligand™, C18: 98% | Solid lipid matrix material, used for solid lipid nanoparticles, sustained-release carriers, and ferulic acid lipid dispersion studies | |
Liquid lipid material | 112-80-1 | Oleic Acid | European Pharmacopoeia (Ph. Eur.), ≥65% | Liquid lipid material, used for nanostructured lipid carriers, stratum corneum lipid interactions, and penetration-enhancement studies | |
Medium-chain oil-phase material | 73398-61-5 | Medium-Chain Triglycerides | USP, European Pharmacopoeia (Ph. Eur.) | Medium-chain oil-phase material, used for nanoemulsions, lipid carrier oil phases, and ferulic acid lipid-phase dispersion studies | |
Emulsifying and lipid matrix material | 123-94-4 | Glyceryl Monostearate, Monoglyceride | ≥99% | Emulsifying and lipid matrix material, used for solid lipid carriers, topical emulsion systems, and sustained release of active ingredients |
Note: The above products are representative Aladdin products related to scientific research and formulation studies. For more information on product specifications, grades, and COA information, please search by product name, CAS number, or catalog number on the Aladdin website.
References
[1] PubChem. Ferulic Acid, C₁₀H₁₀O₄, CID 445858. National Center for Biotechnology Information.
[2] Buanafina, M. M. de O. Feruloylation in Grasses: Current and Future Perspectives. Molecular Plant. 2009;2(5):861–872. doi:10.1093/mp/ssp067.
[3] Zheng, M.; Liu, Y.; Zhang, G.; Yang, Z.; Xu, W.; Chen, Q. The Antioxidant Properties, Metabolism, Application and Mechanism of Ferulic Acid in Medicine, Food, Cosmetics, Livestock and Poultry. Antioxidants. 2024;13(7):853. doi:10.3390/antiox13070853.
[4] Tu, W.; Wang, H.; Li, S.; Liu, Q.; Sha, H. The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases. Aging and Disease. 2019;10(3):637–651. doi:10.14336/AD.2018.0513.
[5] Kim, K.-H.; Jung, J. H.; Chung, W.-S.; Lee, C.-H.; Jang, H.-J. Ferulic Acid Induces Keratin 6α via Inhibition of Nuclear β-Catenin Accumulation and Activation of Nrf2 in Wound-Induced Inflammation. Biomedicines. 2021;9(5):459. doi:10.3390/biomedicines9050459.
[6] Lin, F.-H.; Lin, J.-Y.; Gupta, R. D.; Tournas, J. A.; Burch, J. A.; Selim, M. A.; Monteiro-Riviere, N. A.; Grichnik, J. M.; Zielinski, J.; Pinnell, S. R. Ferulic Acid Stabilizes a Solution of Vitamins C and E and Doubles its Photoprotection of Skin. Journal of Investigative Dermatology. 2005;125(4):826–832. doi:10.1111/j.0022-202X.2005.23768.x.
[7] Pinnell, S. R.; Yang, H.; Omar, M.; Monteiro-Riviere, N.; DeBuys, H. V.; Walker, L. C.; Wang, Y.; Levine, M. Topical L-Ascorbic Acid: Percutaneous Absorption Studies. Dermatologic Surgery. 2001;27(2):137–142. doi:10.1046/j.1524-4725.2001.00264.x.
[8] Das, S.; Wong, A. B. H. Stabilization of Ferulic Acid in Topical Gel Formulation via Nanoencapsulation and pH Optimization. Scientific Reports. 2020;10:12288. doi:10.1038/s41598-020-68732-6.
[9] Kang, Y.; Zhang, S.; Wang, G.; Yan, Z.; Wu, G.; Tang, L.; Wang, W. Nanocarrier-Based Transdermal Drug Delivery Systems for Dermatological Therapy. Pharmaceutics. 2024;16(11):1384. doi:10.3390/pharmaceutics16111384.
For more related articles, see below:
Ferulic Acid: Structural Features, Preparation Routes, and Key Points for Research Applications
Role of Sphingolipid Metabolic Remodeling in Apoptotic and Inflammatory Signaling
How to decipher the whitening code?
Niacin (Vitamin B3): Structural Features, Metabolic Roles, and Application Landscape
The "Six Key Checkpoints" of Skin Lightening
Tyrosinase: a key regulatory enzyme in melanin synthesis and its biological and applied significance
Enzymatic Hydroxylation Mechanism of Salicylate Conversion to Catechol
危险品化学品经营许可证(带存储)